The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
A comprehensive new study supports evidence of the myriad health benefits of GLP-1 medications like Ozempic and Mounjaro — ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Novo Nordisk ( NYSE:NVO) and Eli Lilly ( NYSE:LLY) are making headlines againthis time, for potential benefits beyond weight ...
From Alzheimer's prevention to weight-loss dominance, Novo bets on innovation and share repurchases amid Medicare pressure.
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...
SAN FRANCISCO, CA / ACCESS Newswire / / Gala introduces a groundbreaking digital health platform that simplifies the ...